| Medical and Health Sciences | 2021-2025 | 32 | CN 2 | 99.99 |
| Psychology and Behavioral Sciences | 2021-2025 | 680 | CN 44 | 98.24 |
| Economics and Finance | 2021-2025 | 562 | CN 124 | 97.85 |
| Mathematics and Statistics | 2021-2025 | 669 | CN 155 | 93.88 |
| Health | Lifetime | 443 | CN 7 | 97.15 |
| Obstetrics and Gynecology | Lifetime | 605 | CN 9 | 93.82 |
| Modeling and Simulation | Lifetime | 375 | CN 68 | 90.26 |
| Hepatology | Lifetime | 839 | CN 53 | 82.10 |
| Health | 2021-2025 | 11 | CN 1 | 99.82 |
| Epidemiology | 2021-2025 | 34 | CN 3 | 99.82 |
| Public, Environmental and Occupational Health | 2021-2025 | 77 | CN 4 | 99.36 |
| Infectious Diseases | 2021-2025 | 47 | CN 7 | 99.39 |
| General Health Professions | 2021-2025 | 158 | CN 4 | 98.89 |
| Obstetrics and Gynecology | 2021-2025 | 51 | CN 4 | 98.85 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 87 | CN 6 | 98.63 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 237 | CN 89 | 96.42 |
| Modeling and Simulation | 2021-2025 | 96 | CN 19 | 96.06 |
| Econometrics and Quantitative Economics | 2021-2025 | 770 | CN 161 | 95.13 |
| Clinical Psychology | 2021-2025 | 559 | CN 22 | 94.56 |
| Finance and Banking | 2021-2025 | 148 | CN 11 | 93.74 |
| Virology | 2021-2025 | 58 | CN 2 | 90.05 |
| Cognitive Psychology | 2021-2025 | 423 | CN 32 | 91.17 |
| Organizational Behavior and Human Resource Management | 2021-2025 | 330 | CN 22 | 91.39 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 891 | CN 107 | 87.98 |
| Clinical Neurology | 2021-2025 | 399 | CN 16 | 86.64 |
| Hepatology | 2021-2025 | 259 | CN 21 | 84.28 |
| COVID-19 Impact on Reproduction | Lifetime | 29 | CN 2 | 98.76 |
| COVID-19 Clinical Research Studies | Lifetime | 357 | CN 53 | 98.49 |
| COVID-19 and Mental Health | Lifetime | 230 | CN 19 | 97.83 |
| COVID-19 epidemiological studies | Lifetime | 197 | CN 24 | 98.38 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 607 | CN 92 | 98.04 |
| Vaccine Coverage and Hesitancy | Lifetime | 280 | CN 8 | 97.92 |
| Long-Term Effects of COVID-19 | Lifetime | 485 | CN 34 | 96.39 |
| Hepatitis B Virus Studies | Lifetime | 869 | CN 52 | 97.86 |
| COVID-19 Pandemic Impacts | Lifetime | 175 | CN 26 | 95.77 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 753 | CN 44 | 93.94 |
| Healthcare Systems and Reforms | Lifetime | 994 | CN 91 | 90.94 |
| Poxvirus research and outbreaks | Lifetime | 863 | CN 17 | 87.00 |
| Immune responses and vaccinations | Lifetime | 807 | CN 28 | 82.42 |
| COVID-19 Impact on Reproduction | 2021-2025 | 2 | CN 1 | 99.70 |
| COVID-19 epidemiological studies | 2021-2025 | 7 | CN 2 | 99.57 |
| Health disparities and outcomes | 2021-2025 | 6 | CN 1 | 99.60 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 12 | CN 1 | 99.50 |
| COVID-19 Clinical Research Studies | 2021-2025 | 146 | CN 18 | 99.18 |
| Global Health Care Issues | 2021-2025 | 18 | CN 10 | 98.60 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 185 | CN 27 | 99.16 |
| Global Maternal and Child Health | 2021-2025 | 56 | CN 3 | 98.90 |
| COVID-19 and Mental Health | 2021-2025 | 137 | CN 15 | 98.31 |
| Healthcare Systems and Reforms | 2021-2025 | 28 | CN 5 | 97.65 |
| Pregnancy and preeclampsia studies | 2021-2025 | 98 | CN 11 | 97.98 |
| Long-Term Effects of COVID-19 | 2021-2025 | 252 | CN 8 | 97.13 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 51 | CN 2 | 95.91 |
| Climate Change and Health Impacts | 2021-2025 | 154 | CN 47 | 97.12 |
| Influenza Virus Research Studies | 2021-2025 | 102 | CN 18 | 96.82 |
| Hepatitis B Virus Studies | 2021-2025 | 167 | CN 30 | 96.84 |
| Mosquito-borne diseases and control | 2021-2025 | 264 | CN 13 | 95.96 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 49 | CN 9 | 94.45 |
| Poxvirus research and outbreaks | 2021-2025 | 55 | CN 2 | 94.68 |
| COVID-19 Pandemic Impacts | 2021-2025 | 150 | CN 16 | 94.98 |
| COVID-19 and healthcare impacts | 2021-2025 | 646 | CN 18 | 91.60 |
| Bacillus and Francisella bacterial research | 2021-2025 | 87 | CN 8 | 91.90 |
| Hepatitis C virus research | 2021-2025 | 312 | CN 35 | 95.06 |
| Immune responses and vaccinations | 2021-2025 | 65 | CN 6 | 91.45 |
| Virology and Viral Diseases | 2021-2025 | 121 | CN 15 | 89.75 |
| Chronic Disease Management Strategies | 2021-2025 | 332 | CN 30 | 91.57 |
| Zoonotic diseases and public health | 2021-2025 | 162 | CN 14 | 91.35 |
| Sleep and related disorders | 2021-2025 | 464 | CN 39 | 92.43 |
| HIV-related health complications and treatments | 2021-2025 | 238 | CN 3 | 90.88 |
| Herpesvirus Infections and Treatments | 2021-2025 | 308 | CN 30 | 88.69 |
| Gestational Diabetes Research and Management | 2021-2025 | 420 | CN 59 | 90.31 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 999 | CN 93 | 89.54 |
| Pediatric health and respiratory diseases | 2021-2025 | 311 | CN 31 | 84.42 |
| Travel-related health issues | 2021-2025 | 66 | CN 5 | 85.73 |
| Malaria Research and Control | 2021-2025 | 784 | CN 23 | 87.75 |
| HIV/AIDS Impact and Responses | 2021-2025 | 112 | CN 2 | 82.53 |
| Pneumonia and Respiratory Infections | 2021-2025 | 981 | CN 61 | 86.20 |
| Maternal and fetal healthcare | 2021-2025 | 510 | CN 17 | 87.06 |
| Intergenerational Family Dynamics and Caregiving | 2021-2025 | 373 | CN 50 | 83.19 |
| Data-Driven Disease Surveillance | 2021-2025 | 328 | CN 43 | 76.70 |
| Preterm Birth and Chorioamnionitis | 2021-2025 | 756 | CN 64 | 61.83 |
| Traditional Chinese Medicine and Integrative Care | 2021-2025 | 236 | CN 150 | 63.82 |
| Demographic Trends and Gender Preferences | 2021-2025 | 388 | CN 58 | 56.25 |
